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Abstract
Previous studies from our laboratory have shown that malondialdehyde-acetaldehyde-protein adducts (MAA adducts) are formed in
hepatocytes of ethanol-fed rats and directly influence the hepatic stellate cells (HSCs) to induce their secretion of chemokines and to upregulate their expression of adhesion molecules. Since protein kinase C (PKC) is known to play a major role in many diverse intracellular
signal transduction processes, we investigated whether MAA adducts influence the function of HSCs via a PKC-dependent pathway.
HSCs in culture were exposed to MAA adducts, and PKC activity was determined. We observed a time- and concentration-dependent
activation of PKC when cultures were exposed to BSA-MAA as compared with unmodified BSA. Using PKC isoform-specific inhibitors,
we also showed that BSA-MAA induces the activation of a specific isoform of PKC, PKC-a, in HSCs. No activation of PKC was observed
when HSCs were exposed to other aldehyde adducts such as BSA-acetaldehyde or BSA-malondialdehyde, indicating that the effects of
MAA adducts on HSCs were somewhat specific. We further examined whether the observed increase in PKC activation induced by MAA
adducts in HSCs, in turn, causes a functional effect. We observed that BSA-MAA induces the increased secretion of urokinase-type
plasminogen activator, a key component of the plasmin-generating system, and that PKC activation is necessary for this enhanced
urokinase-type plasminogen activator secretion. These results indicate that MAA adducts via a PKC-mediated pathway may regulate
plasmin-mediated matrix degradation in the liver, thereby contributing to the progression of hepatic fibrosis.

Krq'word.~:MAA adducts; Urokinase-type plasminogen activator; PKC; Alcoholic liver disease; Hepatic stellate cells

1. Introduction
Key players in the pathogenesis of alcohol-induced liver
injury are the HSCs [I-31. HSCs normally reside in the
space of Disse in a quiescent, non-proliferative state, in
close contact with all the major resident liver cells. Following hepatic injury, regardless of etiology, HSCs undergo a
*Corresponding author. Tel.: +I-402-346.8800~3736;
fax: 1-402-449-0604.
E-mail address: kkharbanda@unmc.edu (K.K. Kharbanda).
Ahbreviution,s: HSCs, hepatic stellate cells; ECM, extracellular matrix;
MAA adducts, malondialdehyde-acetaldehyde-protein adducts; MDA,
malondialdehyde; PKC, protein kinase C; PA, plasminogen activator; uPA,
urokinase-type plasminogen activator; PMA, 4P-phorbol 12P-myristate
13-acetate; MCP-I , macrophage chemotactic protein-l ; MIP-2, macrophage inflammatory protein-2; ECL, enhanced chemiluminescence.
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complex activation process and become the principal source
for the increased and irregular deposition of extracellular
matrix (ECM) components, which characterizes fibrosis
and cirrhosis [4-71. In addition, HSCs participate in matrix
remodeling through the synthesis of matrix metalloproteinases, tissue inhibitors of metalloproteinases, cytokines, and
components of the plasminogen-activating systems [8-141.
Many of the toxic effects of ethanol have been linked to
the formation of adducts, resulting from the covalent
binding of highly reactive aldehydes such as acetaldehyde,
malondialdehyde (MDA), and 4-hydroxynonenal, produced
in the liver during ethanol ingestion, to hepatic proteins, as
playing a significant role in the development of liver injury
[15-181. Recent studies from our laboratory have shown
that acetaldehyde, derived from ethanol metabolism, and
the lipid peroxidation-derived aldehyde, MDA, can react
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together with proteins in a synergistic manner to form new
and distinct hybrid adducts, designated as MAA adducts
[19]. Definitive chemical characterization of MAA adducts
has revealed two major structural forms. In addition to the
highly fluorogenic and immunogenic 2: 1 MAA adduct, in
which 2 moles of MDA and I mole of acetaldehyde combine with an amino group of proteins, a 1: I adduct in which
1 mole each of MDA and acetaldehyde combine with an
amino group of a protein has been shown to be the other
major adduct [20]. Studies from our laboratory have shown
that MAA adducts are formed in hepatocytes of ethanolfed rats [2 11 and induce the secretion of two chemokines,
macrophage chemotactic protein- 1 (MCP-I) and macrophage inflammatory protein-2 (MIP-2), as well as increase
the expression of intercellular adhesion molecule- 1 in HSCs
in vitro [22]. These results indicated that the MAA adducts
could directly affect HSCs and contribute to the pathogenesis of alcoholic liver injury.
PKC is known to play a major role in intracellular signal
transduction affecting such processes as proliferation,
differentiation, migration, inflammation, and cytoskeletal
organization. Investigations over the past decade have
shown that many effects of ethanol on cell functions are
closely interconnected with PKC [23]. Since other laboratories have reported the activation of PKC in HSCs consequent to exposure to aldehydes [24,25], in this study we
investigated whether the effects of MAA adducts on HSCs
are transduced via a PKC-dependent pathway. In macrophages, a classical PKC activator, 4P-phorbol 12P-myristate 13-acetate (PMA), has been shown to up-regulate a
key component of the plasminogen activating system,
urokinase-type plasminogen activator (uPA) [26]. Because
both human and rat HSCs have been shown to produce uPA
[I 3,141, we also investigated the effect of MAA adducts on
the secretion of uPA by these cells. We observed that BSAMAA induces the activation of PKC and increases the
secretion of uPA and that PKC activation is necessary for
BSA-MAA-induced enhancement of uPA secretion.

2. Materials and methods
2.1. Materials
BSA (Fraction V, fatty acid-free, low endotoxin), collagenase, Stractan, casein, PMA, and monoclonal antismooth muscle a-actin were obtained from the Sigma
Chemical Co. Acetaldehyde was obtained from the Aldrich
Chemical Co. A chromogenic LAL assay kit was obtained
from BioWhittaker. Pronase and DNAse were from the
Boehringer Mannheim Corp. Dulbecco's modified Eagle's1
F-12 medium (DMEMlF12), glutamine, solutions of antibiotics and an antifungal agent, and trypsin-EDTA were
from Gibco-BRL. Fetal bovine and horse serum were
from HyClone Laboratories. The avidin-biotin peroxidase
kit was from Vector Laboratories. The PKC inhibitors

Go 6976, rottlerin, myristylated-PKC-[, and calphostin
C were obtained from the Calbiochem-Novobiochem
Corp. A Biotrack PKC enzyme assay kit, [ y - " ~ ] ~ ~ ~ ,
and an enhanced chemiluminescence (ECL) immunodetection kit were obtained from Amersham Pharmacia.
Plasminogen and D-Val-Leu-Lys-aminomethyl coumarin
(plasmin substrate) were obtained from Enzyme Systems
Products. Purified uPA and antibody to uPA were obtained
from American Diagnostica Inc. Peroxidase-conjugated
anti-rabbit secondary antibody was from Jackson Immunoresearch Laboratories. Nitrocellulose membrane was
obtained from Bio-Rad. Protein concentration was measured using the BCA protein assay reagent obtained from
Pierce. All other chemicals used in this study were
obtained from the Fischer Scientific Co.
2.2. Generation of BSA-MAA and other adducts
BSA-MAA was generated by incubating I mg/mL of
BSA with an equimolar (I mmollL) solution of MDA and
acetaldehyde for 3 days at 37" in a sealed polypropylene
vessel in a non-oxidizing atmosphere as detailed in our
earlier publication [19]. Unmodified BSA was used as a
control. Additional controls such as acetaldehyde- or MDAadducts of these proteins were made utilizing similar
conditions for incubation and with the same molar concentration of acetaldehyde or MDA alone as used in the
generation of MAA adducts. Since HSCs are responsive
to LPS and results in activation of PKC,~we took utmost
care to generate the various adducts under pyrogen-free
conditions. The endotoxin levels in our adducted and nonadducted samples, monitored using the chromogenic LAL
assay, were always below the detectable range of <0.06
endotoxin units/mL.
2.3. Isolation and culture o f HSCs
Male Wistar rats (Charles River Laboratories) were
maintained at the Omaha VA Medical Center animal
facility accredited by the American Association for the
Accreditation of Laboratory Animal Care (AAALAC). All
animals received humane care in accordance with the
guidelines of the National Institute on Drug Abuse,
National Institute of Health, and the Guide for the Care
and Use of Laboratory Animals (Institute of Laboratory
Animal Resources, Commission on Life Sciences,
National Research Council, 1996).
The HSCs were isolated from 3-month-old rats using
sequential pronase and collagenase perfusion followed by
density gradient centrifugation with Stractan [27]. The
viability of the cells was evaluated by trypan blue exclusion, and HSCs were identified by their typical phase
contrast light microscopic appearance and by the presence
of fat droplets detected by ultraviolet light. The purified

' Kharbanda KK and Tuma DJ, unpublished observations
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HSCs were cultured on uncoated plastic (75-cm2 flask) at
37" in a humidified atmosphere containing 5% C 0 2 as
described by Friedman and Roll [27] in 1:l DMEMlF12
supplemented with 10% fetal bovine serum, 10% horse
serum, 2 mmol/L of glutamine and 1% solutions of antibiotics and an antifungal agent. The medium was replaced
24 hr after seeding the cells and every 48 hr thereafter. At
confluence, the cells were detached with a trypsin-EDTA
solution and split 1:4 each time for subculture. A representative from each subculture was stained by the avidinbiotin peroxidase technique following the instructions of
the manufacturer (Vector Laboratories) using monoclonal
anti-smooth muscle a-actin. Under these culture conditions, HSCs proliferated and became fully activated within
8-10 days of primary culture.
The experiments described in this study were done on 59 independent cell lines and were performed between
passages 1 and 6. The HSCs in passages 1-6, all of which
were smooth muscle a-actin positive (indicating that all
these cells were activated), were trypsinized, and 2.5 x 10"
cells were plated in uncoated 60-mm petri dishes in serum
containing medium for PKC-related studies. When the
plates were 60% confluent, the cells were washed with
medium without serum and exposed to unmodified BSA or
BSA-MAA in serum-free medium for up to 72 hr. At the
end of the exposure time, tissue culture medium was
discarded, 250 yL of cold lysis buffer (50 mmol/L TrisHCl, pH 7.4, containing leupeptin, phenylmethylsulfonyl
fluoride, and aprotinin) was added immediately, and the
dishes were flash-frozen for PKC assay. To establish the
specificity of BSA-MAA, HSCs were also exposed to
BSA-acetaldehyde or BSA-MDA adducts, and the activity
of PKC was determined.

2.5. Effect of BSA-MAA on uPA secretion by HSCs
The secretion of uPA was quantitated by chromogenic
substrate assay, casein zymography, and Western blotting
techniques. For these studies, cells grown in uncoated
24-well plates in serum-containing medium were washed
twice with serum-free medium and incubated with BSAMAA or unmodified BSA in 1 mL of serum-free DMEMI
F12 for 24 hr. After incubation, the media were collected,
centrifuged at 10,000 g for 7 min at 4", and the supernatants were stored at -70" until assay. The cells were
lysed in 250 yL of 0.1 % SDS to determine total DNA [29].
2.6. Determination of uPA activity by chromogenic
substrate assay
Quantification of uPA activity in the conditioned medium was performed utilizing a functional assay for plasmin
[26]. Briefly, purified uPA or aliquots (300 pL) of serumfree supernatants of conditioned medium were added to
tubes with buffer (PBS, pH 7.6, with 0.05% Tween-20).
Then 5 pg of plasminogen and 13 pg of the plasmin substrate D-Val-Leu-Lys-aminomethyl coumarin were added
to all tubes. Each conditioned medium sample had its own
blank in which no plasminogen was added. This was done
to eliminate interference in the assay by plasmin or other
non-specific proteases in the sample. Samples were mixed
and incubated in a 37" water bath. The concentration of
aminomethyl coumarin produced was measured fluorometrically at excitation and emission wavelengths of 370 and
460 nm, respectively. Activity of plasminogen activator
(PA) in the conditioned medium was extrapolated from a
standard curve utilizing purified uPA, and the data were
expressed as mIU/yg of DNA.

2.4. Assay of PKC activity
2.7. Casein zymography
The cells were scraped from dishes and sonicated. The
cell lysate was centrifuged at 10,000 g for 30 min at 4" to
separate the cytosolic and particulate fractions. The particulate fraction was extracted with lysis buffer containing
Triton X- 100. PKC activity was determined in both fractions by a procedure employed previously [28] using the
substrate peptide (VRKRTLRRL) in 20 yL of kit mix and
20 pL of M ~ - [ ~ - ' ~ P ] A TinP a Tris-HC1 buffer (pH 7.5).
Samples (20 pL) were added to 40 yL of the above reaction
mixture and incubated for 15 min at 30". Incubations were
stopped by spotting 50 pL of each sample onto P-81
phosphocellulose paper (Whatman). The papers were
washed five times for 5 min each in 75 mmol/L of phosphoric acid and one time in ethanol and then air-dried and
counted in non-aqueous scintillant. Kinase activity was
calculated in relation to total cellular protein assayed and
was expressed in pmol/(min mg). No less than three
independent tests on different cellular preparations were
performed per parameter. Data were analyzed for statistical
significance using Student's t-test.

For the detection of PA by zymography, samples of
conditioned media were separated on 10% SDS-polyacrylamide gels containing 2 mg/mL of casein and 0.25 mg/mL
of plasminogen under non-reducing conditions according
to the zymography procedure of Waghray and Webber
[30]. The volume of the conditioned medium loaded per
lane was such that it corresponded to an equal cell number
or DNA amount. After electrophoresis, the gels were
incubated for 30 min in a 2.5% solution of Triton X-100
and then incubated overnight at 37" in 50 mmol/L of Tris,
100 mmol/L of NaCl, pH 7.6. The gels were stained with a
0.5% solution of Coomassie blue and destained in 30%
methanol and 10% acetic acid. The uPA activity (caseinolytic activity) was identified as clear bands on a uniform
blue background following destaining. The gels were
dried, and densitometric analyses were performed using
the Molecular Dynamics personal SI and ImageQuant
software. To rule out the possibility that the activity being
determined by casein zymography was not due to plasmin,
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conditioned media were also separated in casein-SDSpolyacrylamide gels in the absence of plasminogen.

2.8. Western blotting
Samples of conditioned media (corresponding to an
equal cell number or DNA amount) in electrophoresis
loading buffer [SOmmollL of Tris-HC1 (pH 6.8), 2%
SDS, 2% P-mercaptoethanol, 10% glycerol, and 0.001%
bromophenol blue] were separated on a 10% SDS-polyacrylamide gel. Protein transfer was performed onto a
nitrocellulose filter using a transblot apparatus containing
25 mmol/L of Tris-HC1 (pH 8.3), 192 mmol1L of glycine,
and 20% methanol. The blots were blocked for 1 hr at 37"
with Blotto (PBS, pH 7.4,0.05% Tween-20,5% nonfat dry
milk) and then were incubated overnight in Blotto containing 1:1000 diluted polyclonal antibody against uPA. After
extensive washing in PBS-Tween-20, the blots were incubated for 1 hr at 25" in Blotto containing 0.5 pg1mL of
peroxidase-conjugated anti-rabbit secondary antibody.
Blots were washed extensively with PBS-Tween-20,
washed once with PBS, developed using ECL, and exposed
to film. Densitometric analyses were performed using
the Molecular Dynamics personal SI and ImageQuant
software.

2.9. Statistical analysis
Statistical analysis was performed by the paired Student's t-test. A probability value of <0.05 was considered
significant.

0.25 2

3. Results
To examine whether BSA-MAA activates PKC in
HSCs, we initially exposed HSCs to 50 pglmL of BSAMAA or unmodified BSA for up to 72 hr. We observed a
time-dependent activation of PKC activity in HSCs treated
with 50 pg1mL of BSA-MAA (Fig. 1). BSA-MAA maximally activated PKC (2.0-fold increase, P < 0.05) at 2 hr
after exposure compared to the medium control and
decreased to unstimulated levels by 24 hr and remained
so at 48 and 72 hr (Fig. 1). In contrast to BSA-MAA, there
was no effect of unmodified BSA on PKC activation at any
of the time points tested. To determine the concentrationdependent effect of BSA-MAA on HSCs, the cells were
treated with 0-100 pg1mL of BSA-MAA for 2 hr. We
observed a concentration-dependent activation of PKC
up to 62.5 pglmL, beyond which a decrease in PKC
activity was observed (Fig. 2). To establish the specificity
of the BSA-MAA response, we also examined other
aldehyde adducts. At a concentration similar to that of
BSA-MAA, which induced activation of PKC, no effect of
50 pglmL of BSA-acetaldehyde or BSA-MDA adduct
was observed at either 2 or 24 hr of treatment (Table I).
Rat HSCs have been shown to express at least four
[31]. To
different PKC isoforms: PKC-a, -6, -8, and
further delineate which isoform of PKC is activated by
BSA-MAA, we used isoform-specific inhibitors I hr
before exposing the cells for 2 hr to 50 pg1mL of BSAMAA. The various inhibitors used were 100 nmollL of Go
6976 (PKC-a specific inhibitor), 2 pmollL of rottlerin
(PKC-6 specific inhibitor), 40 nmollL of myristylated-

-c

24

48

72

Time (hr)
Fig. I. Time course of BSA-MAA-induced PKC activation. PKC activity was determined in HSCs exposed to medium alone (a),50 pg/mL of unmodified
BSA ( O ) ,or 50 pg/mL of BSA-MAA (V)for up to 72 hr. PMA (v)at a concentration of 100 ng/mL was used as a positive control. Results are presented as
means SEM of four determinations. An asterisk (*) indicates that the value is significantly different (P < 0.05) from the medium-alone control.
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BSA-MAA (yglmL)
Fig. 2. Concentration-dependent effect of BSA-MAA on PKC activation. HSCs were exposed to different concentrations of BSA-MAA (0-100 pg/mL) for
2 hr, and PKC activity was determined. Results are presented as means f SEM of four determinations. HSCs were incubated with serum-free medium alone
for 2 hr as a control. An asterisk (*) indicates that the value is significantly different (P < 0.05) from the control.

PKC-I (PKC-I specific inhibitor), or 1 pmol/L of calphostin C (isoform-indiscriminate general PKC inhibitor). Of
all the inhibitors tested, only Go 6976, the PKC-c~specific
inhibitor, and calphostin C, an isoform-indiscriminate
inhibitor, were able to inhibit the BSA-MAA-induced
increase in PKC translocation, whereas rottlerin or myristylated-PKC-[ had no effect (Fig. 3), indicating that the
effects of MAA are mediated via the PKC-a isoform and
not the PKC-S or the -[ isoform.
We next examined whether BSA-MAA-induced PKC
activation could, in turn, modulate PA secretion by HSCs.
HSCs were exposed to 50 pg/mL of BSA-MAA or the
unmodified BSA for 24 hr, and the PA activity in the
conditioned medium was quantified by a chromogenic
substrate assay. We detected an -2-fold increase in PA
secretion by HSCs exposed to BSA-MAA as compared
with the BSA-treated control (Fig. 4). It should be pointed
out that when employing the chromogenic substrate assay,
the only PA activity that we could demonstrate was with
Table 1
Effect of other aldehyde BSA-adducta on PKC activation
PKC activity (pmol/(min mg) protein)

Unmodified BSA (control)
BSA-acetaldehyde
B SA-MDA

2 hr

24 hr

129.3 f 30.4
142.3 f 20.8"
103.6 f 25.6"

93.6 42.3
147.6 & 5.2"
144.6 14.5"

*

+

HSCS were exposed to 50 pg/mL of unmodified BSA, BSAacetaldehyde or BSA-MDA adducts for 2 and 24 hr, and the activity of
PKC was determined as detailed in Section 2. Results are means & SEM
( N = 4).
"Not significantly different from its corresponding control.

using the conditioned medium. Leyland et al. [13], using
acid glycine to dissociate protein-receptor interactions,
had shown cell-surface associated PA in HSCs. However,
we could not detect any cell receptor-associated PA activity
when the cell surface was stripped with acid glycine.
The PA activity in the conditioned medium of the HSCs
was also determined by casein-plasminogen-SDS-PAGE
zymography. The underlying principle behind this technique is that following electrophoresis and renaturation, PA
converts plasminogen, which is incorporated in the polyacrylamide gel, to plasmin which degrades the casein that
is also incorporated into the gel. The degraded area appears
unstained following staining with Coomassie blue. Not
only is this technique widely used to semi-quantify PA
activity, but it also gives an accurate determination of
the molecular mass of the plasminogen activator. When
conditioned media from HSCs were analyzed by the casein
zymography technique, a prominent lytic band corresponding to a molecular mass of -33 kDa was observed (Fig. 5).
Densitometric analysis revealed a 2.2-fold increase in
uPA secretion by HSCs treated with BSA-MAA as compared to those treated with BSA. NO lytic bands were
observed when the conditioned medium from cells exposed
to either unmodified BSA or BSA-MAA-treated samples
were analyzed by zymography in SDS-polyacrylamide
gels containing only casein (data not shown). This indicated that plasmin was not being secreted by HSCs under
basal or BSA-MAA-induced conditions. The conditioned
medium obtained from these cells was also analyzed by a
Western blotting technique using an antibody to uPA.
Results showed a single sharp band representing the
33 kDa uPA in medium from BSA-MAA or unmodified

.-

++ BSA-MAA I

Fig. 3. Effect of PKC isoforn-specific inhibitors on BSA-MAA-stimulated PKC activation. HSCs were exposed to isoforn-specific inhibitors 1 hr before the
addition of 50 pg/mL of BSA-MAA for 2 hr. The various inhibitors used were 100 nmollL of Gii 6976 (PKC-a specific inhibitor), 2 pmol/L of rottlerin
(PKC-S specific inhibitor), 40 nmolL of myristylated-PKC-l; (PKC-1; specific inhibitor), or 1 pmolL of calphostin C (isoform-indiscriminate PKC inhibitor).
HSCs were incubated with serum-free medium alone for 2 hr to serve as a control. Results are presented as means f SEM of four determinations. An asterisk
(*) indicates that the value is significantly different (P < 0.05) from the control. No significant difference was observed when the samples treated with BSAMAA alone were compared with samples treated with myristylated-PKC-i; BSA-MAA or rottlerin BSA-MAA.
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Unmodified
BSA

u

J

a

+

0
Unmodified BSA

BSA-MAA

Fig. 4. Effect of BSA-MAA on PA activity in the conditioned medium.
HSCs were exposed to 50 pg/mL of unmodified BSA or BSA-MAA for
24 hr, and the PA activity was determined in the conditioned medium using
the chromogenic substrate assay as detailed in Section 2. Results are
presented as means & SEM (N = 4 different cellular preparations). An
asterisk (*) indicates that the value is significantly different (P < 0.0008)
from its corresponding control.

BSA-MAA

Fig. 5. SDS-PAGE zymograms showing the effect of BSA-MAA on the
secretion of uPA. The conditioned medium of HSCs exposed to 50 pg/mL
of unmodified BSA or BSA-MAA for 24 hr was analyzed by SDS-PAGE
zymography using plasminogen and casein as substrates as described in
Section 2. Each column represents the mean SEM (N = 9 different
cellular preparations) of the volume integration units. An asterisk (*)
indicates P < 0.0006. The zymogram shown above the columns is from
one representative experiment. Lanes 1 and 2, BSA; lanes 3 and 4, BSAMAA. The lytic bands correspond to a molecular mass of 33 kDa.
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Fig. 6. Western blot analysis showing the effect of BSA-MAA on the
secretion of uPA. Conditioned medium of HSCs exposed to 50 pg/mL of
unmodified BSA or BSA-MAA for 24 hr was separated on 10% PAGE,
and proteins were transblotted onto nitrocellulose and stained with
antibody to uPA as detailed in Section 2. Blots are from two separate
experiments. The bands correspond to a molecular mass of 33 kDa. Lanes
1 and 3, BSA; lanes 2 and 4, BSA-MAA. The densitometric analyses,
represented as mean volume integration units, are BSA, 51.9; BSA-MAA,
83.7.

BSA-treated HSCs (Fig. 6). This was similar to what was
observed on the casein zymograms. Additionally, the
Western blots corroborated our results obtained by both
the chromogenic substrate assay and casein zymography,
verifying that BSA-MAA induces increased secretion of
33 kDa uPA. It is noteworthy that the 33 kDa moiety
corresponds to the active low molecular mass uPA, which
has been shown to be devoid of binding sites for the uPA
receptor on the cell surface. This could explain why we did
not detect any cell-bound uPA in our chromogenic substrate assay.
To determine whether this BSA-MAA-induced increase
in uPA was mediated via a PKC-dependent pathway,
calphostin C, a PKC inhibitor, was added to the cells
1 hr before the addition of unmodified BSA or BSA-

a
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200
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Calphostin C

BSA

BSA-MAA

Fig. 7. Effect of calphostin C, a PKC inhibitor, on BSA-MAA-induced uPA
activity in the conditioned medium analyzed by SDS-PAGE zymograms.
HSCs were preincubated with or without 1 prnolk of calphostin C for 1 hr
in serum-free medium. Then unmodified BSA or BSA-MAA (50 pg/mL
each) was added, and cells were incubated for another 24 hr. Conditioned
medium was recovered and assayed for PA activity by SDS-PAGE zymography using plasminogen and casein as substrates as described in Section
2. Each column represents the mean of the volume integration units f SEM
(N = 5 different cellular preparations). An asterisk (*) indicates a value
significantly different (P < 0.01) from the control. The zymogram shown
above the columns is from one representative experiment. Lane 1, BSA,
lane 2, calphostin C BSA; lane 3, BSA-MAA; and lane 4, calphostin
C BSA-MAA.
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MAA for 24 hr. We observed that calphostin C was able
to abrogate significantly the BSA-MAA-induced uPA
secretion by 90%, but had no effect on the constitutive
secretion of uPA (Fig. 7).

4. Discussion
In this study, we investigated the role of the PKC pathway in the transductional effects of MAA adducts on HSCs
and their downstream effects. Our present study provides
evidence that BSA-MAA utilizes the activation of a
specific isoform of PKC, PKC-a, as a possible pathway
of signaling events in HSCs. Furthermore, our results
indicate that PKC activation is necessary for BSAMAA-induced uPA secretion.
In experiments reported here, BSA-MAA induced a
time-dependent activation of PKC in HSCs. Peak stimulation of PKC was observed 2 hr after exposure to BSAMAA. In contrast to BSA-MAA, unmodified BSA did not
stimulate PKC activity at any of the time points tested. The
specificity of BSA-MAA on PKC activation in HSCs was
also established by evaluating the effects of other aldehyde
adducts. When examined at a concentration similar to that
of BSA-MAA, which induced activation of PKC, no effect
of BSA-acetaldehyde or BSA-MDA adduct was observed
at either 2 or 24 hr of treatment. In addition to the timedependent activation of PKC by BSA-MAA, we also
observed a concentration-dependent stimulation of PKC
activity in HSCs treated with 0-62.5 pg/mL of BSA-MAA
for 2 hr. Although we observed a stimulation of PKC
activity at 75 and 100 yg/mL of BSA-MAA as compared
with the control, the stimulation in kinase activity was less
than that observed at 50 and 62.5 pg/mL of BSA-MAA.
We believe that we did not observe a concentration-dependent stimulation in PKC activity when HSCs were exposed
to >62.5 pg/mL of BSA-MAA for 2 hr because of the
possible down-regulation or auto-inhibition of PKC activity at 2 hr when exposed to concentrations of BSA-MAA
greater than 62.5 yg/mL. Such concentration- and timedependent down-regulation of PKC has been documented
in cells exposed to PMA, a known activator of PKC [32-341.
Since rat HSCs have been shown to express at least four
different PKC isoforms, PKC-a, -6, -E, and -[[31], we also
examined which PKC isoforms were activated by using
isoform-specific inhibitors before exposing the cells to
BSA-MAA. Of all the inhibitors tested, only Go 6976
and calphostin C were able to inhibit the increase in PKC
translocation, indicating that the effects of BSA-MAA in
HSCs are likely mediated via the PKC-a isoform.
We previously reported that BSA-MAA causes
increased secretion of MCP-1 and MIP-2 by HSCs [22].
However, our observations that PKC inhibitors were
unable to abrogate or mitigate the MAA-induced chemokine secretion (see footnote 1) implied that BSA-MAA
does not utilize the PKC-mediated pathway to increase
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MCP-1 or MIP-2. We then explored other possible functional downstream effects of PKC activation in HSCs. The
observations that PMA, a classical PKC activator, stimulates uPA expression in macrophages [26] and that rat
HSCs produce uPA [I31 led us to investigate whether
BSA-MAA-induced PKC stimulation could, in turn, modulate PA secretion by HSCs. When HSCs were exposed to
BSA-MAA, there was an increase of uPA secretion in the
treated cells compared with the control cells, as quantified
by the chromogenic substrate assay. These results on the
BSA-MAA-induced increase in uPA were also corroborated by casein zymography. The advantage of using the
casein zymography technique rather than the chromogenic
substrate assay to semi-quantify the PA activity is that the
molecular mass of the active moiety can be determined.
Additionally, since HSCs have also been shown to secrete
plasminogen activator inhibitor [35] and while the casein
zymography technique will separate the inhibitor from the
PA during electrophoresis, there is a probability of the
inhibitor interfering in the chromogenic substrate assay,
which could result in an underestimation of the PA activity.
Because of the advantages listed above, we performed
casein zymography and observed a significant increase
in MAA-induced uPA secretion. To rule out the possibility
that BSA-MAA is inducing the secretion of plasmin by the
HSCs, the conditioned media were also separated on 10%
SDS-polyacrylamide gels containing only 2 mg/mL of
casein and no plasminogen. The lack of any lytic bands
in these gels confirmed that the HSCs are induced to
secrete uPA, and not plasmin, after exposure to BSAMAA. Both Western blot analysis and casein zymography
revealed that BSA-MAA increases secretion of 33 kDa
low molecular mass uPA. It was particularly intriguing that
BSA-MAA induced an -2-fold activation in PKC as well
as an -2-fold increase in secretion of uPA by HSCs.
Furthermore, we observed that calphostin C was able to
not only abrogate MAA-induced PKC activation, but also
MAA-induced uPA secretion. The uPA activity measurements were obtained at 24 hr, well after the PKC activity
has returned to unstimulated levels. This is a classical
example of the signal transduction pathways where a
cascade of events that are temporally and spatially linked
takes place. Taken together, our results imply that the effect
of BSA-MAA on promoting uPA secretion is mediated via
a PKC-dependent pathway.
We have demonstrated for the first time that exposure of
HSCs to MAA adducts can stimulate PKC activation,
which leads to increased uPA secretion. We do not know
at present whether the increased uPA secretion induced by
BSA-MAA is a result of increased uPA gene expression or
post-transcriptional modulation. The mechanism by which
MAA adducts activate PKC is also presently unknown.
However, we believe that the interaction of MAA adducts
with surface receptors on HSCs results in the activation of
PKC and generation of its downstream effects. In this
regard, a family of receptors, classified as scavenger

receptors [36], which are known to bind and endocytose
a wide variety of aldehyde-adducted proteins, is a possible
candidate for binding MAA adducts and initiating signaling events that lead to increased uPA secretion. Our
hypothesis is supported by the report that binding of
fucoidan or acetylated low-density lipoprotein to scavenger receptors on a macrophage cell line induces uPA
expression via a PKC-mediated signaling pathway [37].
Current studies are in progress to investigate this mechanism.
In the studies reported here, we provide evidence that
MAA adducts increase secretion of uPA by HSCs via a
PKC-dependent pathway. The implications of our results
are potentially important. The serine protease uPA cleaves
its specific and intrinsic substrate, plasrninogen, to generate plasmin. The broad-spectrum proteinase, plasmin,
degrades fibrin and other components of the ECM [38],
thereby playing an important role in physiological and
pathological pathways involving cell migration and tissue
remodeling. In addition, plasmin also regulates the activity
of some members of the metalloproteinases that require
activation, e.g. interstitial collagenase and stromelysin
[39]. Through proteolysis, uPA also activates pre-interleukin 8, hepatocyte growth factor, and vascular endothelial
growth factor, and, via generation of plasmin, it activates
transforming growth factor-p [4042]. Thus, the plasmingenerating system associated with HSCs plays a central
role in the control of HSC biology by both regulating
pericellular matrix degradation and activating fibrogenic
growth factors. Beyond its role as a facilitator of extracellular proteolysis and an activator of growth factors, uPA
has been reported to induce proliferation of HSCs [14].
Thus, BSA-MAA, by inducing increased uPA secretion by
HSCs, could play a profound role in the perpetuation of
alcoholic liver disease through matrix remodeling, generation of the most potent profibrogenic factor, transforming
growth factor-P, and increased proliferation. Secretion of
uPA has been shown to be increased by agents such as
platelet-derived growth factor, basic-fibroblast growth factor, acetaldehyde, and retinoic acid, all of which have been
shown to play an important role in the pathogenesis of
alcoholic liver disease [13,14,43]. Thus, BSA-MAA can
be added to the list of factors that may play an important
role in the initiation and pathogenesis of alcoholic liver
disease.
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